Filing Details
- Accession Number:
- 0001209191-18-008456
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-08 16:47:29
- Reporting Period:
- 2018-02-08
- Accepted Time:
- 2018-02-08 16:47:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 816284 | Celgene Corp | CELG | Pharmaceutical Preparations (2834) | 222711928 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1538897 | J Mark Alles | C/O Celgene Corporation 86 Morris Avenue Summit NJ 07901 | See Remarks | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-08 | 3,260 | $91.90 | 178,904 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,924 | Indirect | 401(K) |
Billionaire Hedge Funds
